Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences
Pharmaceutical
Sciences Conference | Pharmaceutical
Sciences Conferences | Drug
Discovery Conference | Medicinal Chemistry
Conference | Pharmacological
Sciences Conference | Clinical
Trials Conference | Pharma
Conference | Drug Safety
Conference | Pharmacovigilance
Conference | Pharmaceutical
Sciences Events | Pharmaceutical
Sciences Meetings | Pharmaceutical
Sciences Gatherings
We are very proud and honoured to announce that members of our committee will
be hosting the Pharmaceutical
Sciences conference, which will provide a meaningful framework for
meaningful interactions, engagement, and connection.
As stated in the title, the purpose of the meeting is to
bring together scientists from academia and industry to present cutting-edge
research on advancements in polymer
science and technology in all of its main aspects, with a special emphasis
on those aiming to preserve and improve the health of the planet and of people.
The drug discovery industry has become such a competitive
market that finding better drug
discovery technologies is a constant challenge. This industry must discover
and develop novel
medicines for a wide range of diseases in a market that is likely to face
increased regulatory challenges, pricing pressures, and a variety of other
bottlenecks.
Eminent keynote speakers and delegates from academia and
industry will share their expertise, and opportunities for students, other
fellow researchers, academicians, and industrialists to share their work on a
global platform will be provided.
Market Analysis:
Pharmaceutical
market research analysis can confirm a product's potential market reach and
market penetration capabilities. It is used by investors to determine the worth
of pharmaceutical
companies and their product pipelines. These businesses use it to keep track of
their competitors, identify potential unmet needs, and determine the worth of
their products. Donors and grant providers use PMRA to identify drugs being
developed to treat specific diseases as well as their likelihood of providing a
cure for the disease they represent.
According to a recent Pharma market research report by The
Business Research Company, the global pharmaceuticals
market was worth $934.8 billion in 2017 and will reach $1170 billion in 2022,
growing at a 5.8 percent annual rate. This is a faster rate than the previous
year's 5.2 percent, but it is slower than the other two major healthcare
segments, medical equipment and healthcare services. Healthcare as a whole is
growing at a rate of more than 7% per year. Part of the reason for the Pharma
market's current slow growth is that major new product launches have slowed,
and companies are limiting their R&D investment.
For example, despite the enormous potential for any
effective and safe new drug for treating Alzheimer's disease, Pfizer has
discontinued its Alzheimer's research programme, while AstraZeneca and GSK have
reduced their investments. According to Deloitte, high failure rates, the $2
billion average cost of developing a new drug, and falling returns on
investment for big Pharma companies, down from 10.1 percent a year in 2010 to
3.2 percent in 2017, are restraining the launch of high-priced new breakthrough
drugs like those that boosted the market in previous years. The majority of
pharmaceutical industry growth now comes from the growing global ageing
population, which increases demand for long-term treatments for chronic
diseases and better access to healthcare in emerging economies.
Current Research trends:
The pharmaceutical industry is undergoing a massive
transformation. Historically slow to adopt technology, the industry is now undergoing
rapid change as a result of the development of several technologies. Artificial
intelligence (AI), additive manufacturing, blockchain, and other Industry 4.0
technologies are among the prominent pharma
industry trends. Increased investments, the growth of technology startups, the
expiration of several key patents, as well as increased inter-organizational
collaborations and a favourable regulatory environment, are all driving
innovation in the pharmaceutical industry.
With ever-increasing pressure to compete in a challenging
economic and technological environment, pharmaceutical
and biotech companies must constantly innovate their R&D programmes to stay
ahead of the game. Several important trends affecting the biopharmaceutical
industry have been summarised, including:
·
Various aspects of gene editing technologies are
being advanced.
·
A growing emphasis on microbiome research
·
The use of artificial intelligence (AI) in drug
discovery and development
·
A contentious but rapid expansion in the field
of medical cannabis
·
Pharma's continued emphasis on engaging in
R&D outsourcing models to gain access to innovations and expertise.
Scope and importance of Pharmaceutical science:
Pharmaceutical
Sciences encompasses a broad range of scientific disciplines, including
drug discovery and development, as well as a variety of therapies.
Pharmaceutical sciences are broadly classified into the following categories,
with numerous sub-specialties and sub-categories within each. Some of the
categories are Drug
Discovery and Design, Drug Delivery, Drug Action, Clinical
Sciences, Drug Analysis, Cost Effectiveness of Medicines (Pharma
co-economics), and Regulatory Affairs.
Every year, the pharmaceutical industry in the United States
produces a slew of new drugs with significant medical benefits. Many of these
drugs are expensive, contributing to rising health-care
costs in both the private and public sectors. Policies to reduce drug prices
and federal drug spending have been considered by policymakers. Such policies
would almost certainly reduce the pharmaceutical industry's incentive to
develop new drugs.
Top 100 Industries:
·
Johnson & Johnson
·
Roche
·
Pfizer
·
Novartis
·
Bayer
·
Merck & Co
·
Sanofi
·
GlaxoSmithKline
·
Fresenius SE & Co.
·
AbbVie
·
Fresenius SE & Co
·
Abbott
·
Eli Lily
·
Boehringer Ingelheim
·
Amgen
·
Bristol-Myers Squib
·
Gilead
·
Astrazenerca
·
Shanghai Pharmaceutical
·
Teva
·
Novo Nordisk
·
Cycle Pharma
·
Takeda
·
Allergan
·
Celgene
·
Biogen
·
Astellas Pharma
·
Otsuka
·
Mylan
·
Baxter International
·
Daiichi Sankyo
·
Bausch Health
·
Teijin
·
Regeneron
Top 100 Universities:
Pharmaceutical
Sciences Conference | Pharmaceutical
Sciences Conferences | Drug
Discovery Conference | Medicinal Chemistry
Conference | Pharmacological
Sciences Conference | Clinical
Trials Conference | Pharma
Conference | Drug Safety
Conference | Pharmacovigilance
Conference | Pharmaceutical
Sciences Events | Pharmaceutical
Sciences Meetings | Pharmaceutical
Sciences Gatherings
·
University of Oxford
·
Monash University
·
Harvard University
·
University of Cambridge
·
University of Nottingham
·
University of North Carolina, Chapel Hill
·
University College London (UCL)
·
University of California, San Francisco
·
Johns Hopkins University
·
University of Toronto
·
The University of Manchester
·
National University of Singapore (NUS)
·
University of California, San Diego (UCSD)
·
Karolinska Institutet
·
King's College London
·
ETH Zurich - Swiss Federal Institute of
Technology
·
Leiden University
·
Yale University
·
The University of Tokyo
·
University of British Columbia
Top 100 hospitals:
·
U.S. Department of Health & Human Services
·
National Institutes of Health
·
Institut National de la Sante et de la Recherche
Medicale
·
Veterans Affairs Medical Centers
·
Instituto de Salud Carlos III
·
Johns Hopkins Medicine
·
Howard Hughes Medical Institute
·
National Cancer Institute
·
Assistance Publique Hopitaux de Paris
·
Cancer Research UK
·
Dana Farber Cancer Institute
·
Centers for Disease Control and Prevention
·
Massachusetts General Hospital
·
City of Hope
·
Institute of Cancer Research
·
National Institute of Biomedical Imaging and
Bioengineering
·
Scripps Research Institute
·
University of Texas M.D. Anderson Cancer Center
·
Mayo Clinic
·
Barbara Ann Karmanos Cancer Institute
·
University of Pennsylvania Health System
·
Memorial Sloan-Kettering Cancer Center
·
Broad Institute of MIT and Harvard
·
Broad Institute of MIT and Harvard
·
Medical Research Council
·
Brigham and Women's Hospital
·
West China Hospital
·
World Health Organization
·
Robert H. Lurie Comprehensive Cancer Center
·
University of Michigan Health System
·
Mount Sinai Health System
·
Walter and Eliza Hall Institute of Medical
Research
·
Yale University Health & Medicine
·
Wistar Institute
·
National Institute of Allergy and Infectious
Diseases
·
Stanford Medicine
·
World Health Organization, Switzerland
·
Duke Medicine